Hypertension: Improving patient compliance and clinical outcomes through community pharmacist managed care
|Chief Investigator:||Dr Jeffery Hughes|
The objective of this study was to evaluate a hypertension disease management model for community pharmacists. The study aimed to assess the effectiveness of a community pharmacy-based hypertension disease state management program on improving blood pressure (BP) control, patient adherence, quality-of-life, lifestyle modification rates, and diminishing cardiac risk and cardiovascular disease events. The study also sought to assess the impact of the program on health care resource consumption and health costs, although this component of the research was not ultimately carried out.
A randomised controlled trial study design was employed. A comparison was to be made between patients receiving standard care (control group), and those receiving the intervention at a low rate and at a high rate.
A recruitment target of 300 patients was set to provide adequate power to detect significant differences from the intervention. However, thirty-four patients were enrolled into the study and 21 completed the study follow-up period. There were seven patients in each of the study groups
Recommendations from the study are limited due to the recruitment issues. However, the report made the following points that may help to improve client recruitment:
- Possible inducements for pharmacists to recruit (i.e. payment above their base salary
- Possible inducements for patients to participate (e.g. provision of a blood pressure monitor)
- Site pharmacists with dedicated to the study and unconnected to normal pharmacy business services (this removes barriers related to need to service customers, rather than focusing on recruiting and following up trial participants)
- Increased numbers, mix and locations of study sites with smaller individual recruitment targets.